Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by Pareto8020on Feb 10, 2021 10:08am
160 Views
Post# 32524110

Tweet Blowback

Tweet BlowbackIf Sirona doesn't release some news soon they are just going to be completed torched every time they tweet.  They are already getting slammed on Twitter so if they don't deliver soon it is just going to get uglier and uglier..... and rightly so.  If Howard comes out and says they can't announce anything again because the company they are dealing won't let them I think every investors head will explode.... and we should then vote his buttocks out of the CEO chair at AGM.

 
Micha Molzberger
@MichaMolzberger
·
Feb 9
Replying to 
@SironaBiochem
Hard to  money without  product
Daccord
@Daccord2020
·
23h
Replying to 
@SironaBiochem
Yeah, you are starting to look like Peter, the one with the wolf syndrome, I’m afraid the day you finally come out with a product , nobody listens anymore.
Peter Germershausen
@DynamoGermi80
·
Feb 9
Replying to 
@SironaBiochem
So we need some deals and partnerships for our component. Flexed biceps
.
@TW8810
·
Feb 9
And a product. Until then everything is just bla bla bla
K Clifford
@KCliffo01982271
·
Feb 9
Replying to 
@SironaBiochem
Hangry for 1067? Rodan and Fields will be the first place to go for this product, we all can’t wait, really.
George
@George89986161
·
Feb 9
What if they never use it?
K Clifford
@KCliffo01982271
·
23h
Well if that was the case, Sirona would tell us.  But I think we are in good hands here.
George
@George89986161
·
23h
Yeah, sure they would.
 
KaiUweSkywalker
@SkywalkerUwe
·
18h
Replying to 
@SironaBiochem
„As a sirona shareholder, u wouldn’t believe how many messages I read on forums about other frustrated shareholder of this company“
George
@George89986161
·
Feb 9
Replying to 
@SironaBiochem
Such a huge market, and yet we can't sign any buyers except Rodan and Fields, who seem to have no interest in selling it? Is there a problem with 1067?
John Knig
@JohnKnig2
·
Feb 9
Guten Tag , warum hat denn ein Pharmaunternehmen die jetzige klinische Studie zum Hautaufheller TF-1067 untersttzt ?
Bestimmt nicht aus Nchstenliebe sondern weil es vermutlich Interesse an diesem Hautaufheller hat.Smiling face with sunglasses
George
@George89986161
·
Feb 9
We can only hope. I have been hoping for years.
 
<< Previous
Bullboard Posts
Next >>